LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 58

Search options

  1. Article: The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the "different disease" hypothesis.

    Hundahl, S A / Phillips, J L / Menck, H R

    Cancer

    2000  Volume 88, Issue 4, Page(s) 921–932

    Abstract: Background: A high proportion of U.S. patients with gastric carcinoma do not receive surgical ... frequently, stage- stratified survival for Japanese Americans appears to be superior. In the U.S., surgical ...

    Abstract Background: A high proportion of U.S. patients with gastric carcinoma do not receive surgical treatment. To sharpen staging criteria and facilitate comparisons with surgical series, an analysis of patients whose treatment included gastrectomy was undertaken. In addition, to evaluate the "different disease" hypothesis as an explanation for superior Japanese results, outcomes for Japanese Americans were examined.
    Methods: Data were obtained from National Cancer Data Base (NCDB) reports of 50,169 gastric carcinoma cases diagnosed during the years 1985-1996 and treated with gastrectomy. In addition to demographic and treatment information, 5-year and 10-year relative survival rates are presented, with stage defined according to fifth edition American Joint Committee on Cancer (AJCC) staging procedures.
    Results: Stage-stratified 5-year and 10-year relative survival rates were as follows: Stage IA, 78%/65%; Stage IB, 58%/42%; Stage II, 34%/26%; Stage IIIA, 20%/14%; Stage IIIB, 8%/3%; and Stage IV, 7%/5%. Stage-stratified survival for Japanese Americans was higher. Males had a poorer prognosis than females, and the male-to-female ratio for Japanese Americans was lower. Proximal tumors were associated with a worse prognosis than distal tumors; the proportion of Japanese Americans with proximal disease was less than in the overall patient group. Japanese Americans underwent resection of adjacent organs less frequently. In this series, adjuvant therapy did not substantially affect survival. Overall, 20% were 10-year survivors; of these, 67% were lymph node negative and 98% had </= 8 involved lymph nodes. Five-year stage-stratified survival increased for cases with >/= 15 lymph nodes analyzed. Stage migration was evident in cases with </= 15 nodes examined.<br />Conclusions: The current AJCC/International Union Against Cancer TNM staging system fails to accommodate the effect of proximal location on prognosis. Largely because Japanese Americans present with fewer proximal tumors, have a lower male-to-female ratio, and undergo adjacent organ resection less frequently, stage- stratified survival for Japanese Americans appears to be superior. In the U.S., surgical undertreatment of patients with this disease appears to be a problem.
    MeSH term(s) Aged ; Asian Americans/statistics & numerical data ; Carcinoma/mortality ; Carcinoma/pathology ; Carcinoma/surgery ; Databases, Factual ; Female ; Gastrectomy ; Humans ; Japan/epidemiology ; Japan/ethnology ; Male ; Neoplasm Staging ; Stomach Neoplasms/mortality ; Stomach Neoplasms/pathology ; Stomach Neoplasms/surgery ; Survival Rate ; United States/epidemiology
    Language English
    Publishing date 2000-02-15
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1429-1
    ISSN 1097-0142 ; 0008-543X ; 1934-662X
    ISSN (online) 1097-0142
    ISSN 0008-543X ; 1934-662X
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see commetns].

    Hundahl, S A / Fleming, I D / Fremgen, A M / Menck, H R

    Cancer

    1998  Volume 83, Issue 12, Page(s) 2638–2648

    Abstract: ... now capturing nearly 60% of incident cancers in the U. S. In combination with other Commission ... discussed.: Results: The 10-year overall relative survival rates for U. S. patients with papillary ... of contemporaneous U. S. patients with relatively rare neoplasms, such as thyroid carcinoma. In this context ...

    Abstract Background: The National Cancer Data Base (NCDB) represents a national electronic registry system now capturing nearly 60% of incident cancers in the U. S. In combination with other Commission on Cancer programs, the NCDB offers a working example of voluntary, accurate, cost-effective "outcomes management" on a both a local and national scale. In addition, it is of particular value in capturing clinical information concerning rare cancers, such as those of the thyroid.
    Methods: For the accession years 1985-1995, NCDB captured demographic, patterns-of-care, stage, treatment, and outcome information for a convenience sample of 53,856 thyroid carcinoma cases (1% of total NCDB cases). This article focuses on overall 10-year relative survival and American Joint Committee on Cancer (AJCC) (3rd/4th edition) stage-stratified 5-year relative survival for each histologic type of thyroid carcinoma. Care patterns also are discussed.
    Results: The 10-year overall relative survival rates for U. S. patients with papillary, follicular, Hürthle cell, medullary, and undifferentiated/anaplastic carcinoma was 93%, 85%, 76%, 75%, and 14%, respectively. For papillary and follicular neoplasms, current AJCC staging failed to discriminate between patients with Stage I and II disease at 5 years. Total thyroidectomy +/- lymph node sampling/dissection represented the dominant method of surgical treatment rendered to patients with papillary and follicular neoplasms. Approximately 38% of such patients receive adjuvant iodine-131 ablation/therapy. At 5 years, variation in surgical treatment (i.e., lobectomy vs. more extensive surgery) failed to translate into compelling differences in survival for any subgroup with papillary or follicular carcinoma, but longer follow-up is required to evaluate this. NCDB data appeared to validate the AMES prognostic system, as applied to papillary cases. Younger age appeared to influence prognosis favorably for all thyroid neoplasms, including medullary and undifferentiated/anaplastic carcinoma. NCDB data also revealed that unusual patients diagnosed with undifferentiated/anaplastic carcinoma before age of 45 years have better survival.
    Conclusions: The NCDB system permits analysis of care patterns and survival for large numbers of contemporaneous U. S. patients with relatively rare neoplasms, such as thyroid carcinoma. In this context, it represents an unsurpassed clinical tool for analyzing care, evaluating prognostic models, generating new hypotheses, and overcoming the volume-related drawbacks inherent in the study of such neoplasms. [See editorial on pages 2434-6, this issue.]
    MeSH term(s) Adenocarcinoma/epidemiology ; Adenocarcinoma/mortality ; Adenocarcinoma/pathology ; Adenocarcinoma, Follicular/epidemiology ; Adenocarcinoma, Follicular/mortality ; Adenocarcinoma, Follicular/pathology ; Adolescent ; Adult ; Aged ; Aged, 80 and over ; Carcinoma/epidemiology ; Carcinoma/mortality ; Carcinoma/pathology ; Carcinoma, Medullary/epidemiology ; Carcinoma, Medullary/mortality ; Carcinoma, Medullary/pathology ; Carcinoma, Papillary/epidemiology ; Carcinoma, Papillary/mortality ; Carcinoma, Papillary/pathology ; Child ; Child, Preschool ; Cohort Studies ; Databases as Topic/statistics & numerical data ; Humans ; Infant ; Infant, Newborn ; Middle Aged ; Neoplasm Staging ; Registries/statistics & numerical data ; Survival Rate ; Thyroid Neoplasms/epidemiology ; Thyroid Neoplasms/mortality ; Thyroid Neoplasms/pathology ; United States/epidemiology
    Language English
    Publishing date 1998-12-15
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1429-1
    ISSN 1097-0142 ; 0008-543X ; 1934-662X
    ISSN (online) 1097-0142
    ISSN 0008-543X ; 1934-662X
    DOI 10.1002/(sici)1097-0142(19981215)83:12<2638::aid-cncr31>3.0.co;2-1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Patterns of care for patients with primary differentiated carcinoma of the thyroid gland treated in Germany during 1996. U.S. and German Thyroid Cancer Group.

    Hölzer, S / Reiners, C / Mann, K / Bamberg, M / Rothmund, M / Dudeck, J / Stewart, A K / Hundahl, S A

    Cancer

    2000  Volume 89, Issue 1, Page(s) 192–201

    Abstract: ... with thyroid carcinoma, a Patient Care Evaluation Study was initiated in 1996 in the U.S. and Germany. This project ...

    Abstract Background: To determine current patterns of care and disease characteristics for patients with thyroid carcinoma, a Patient Care Evaluation Study was initiated in 1996 in the U.S. and Germany. This project addresses ongoing concerns with respect to the diagnostic evaluation and treatment of patients diagnosed with thyroid carcinoma and raises questions concerning how physicians are interpreting current standards and acting on the basis of these recommendations.
    Methods: Patients with primary thyroid carcinoma were entered into a prospective multicenter observational study with free choice of treatment (no control group) between January 1, 1996 and December 31, 1996 in Germany. This resulted in a total of 2537 cases under observation and analysis; 1685 patients had papillary carcinoma (66.4%), 691 had follicular carcinoma (27.2%), 70 had medullary carcinoma (2.8%), and 91 had anaplastic carcinoma (3.6%). The 2376 patients with carcinoma of either papillary or follicular histology were included in the current analysis.
    Results: The major symptoms reported for patients with papillary and follicular thyroid carcinoma was neck mass (reported in 76% and 79%, respectively) followed by dysphagia (reported in 25% and 27%, respectively), stridor (reported in 9% and 14%, respectively), and neck pain (reported in 7% and 8%, respectively). Greater than 50% of the patients with papillary thyroid carcinoma were reported to have American Joint Committee on Cancer/International Union Against Cancer Stage I disease. Between 37-39% of the follicular carcinoma patients had Stage I and Stage II disease. Only slight differences in the diagnostic approach to patients with papillary or follicular carcinoma were noted. The majority of patients underwent an ultrasound of the thyroid region (78.1%), which was suggestive of carcinoma in only 39% of the cases. A thyroid scan was performed on 76.6% of patients, and the results were suggestive of carcinoma in 44.8% of the individuals. In contrast, fine-needle aspiration biopsy of the thyroid is highly recommended in the current Clinical Practice Guidelines (CPG) but results were obtained in only 27.4% of the patients. Total thyroidectomy without lymph node dissection was the most commonly used surgical procedure in the treatment of patients with papillary and follicular thyroid carcinoma. Only approximately 2% of patients at low risk in the group with Stage I disease were treated with a lobectomy. In 80% of the patients with Stage I papillary thyroid carcinoma and approximately 90% of those patients diagnosed with Stage II, III, and IV disease treating physicians chose to utilize radioiodine as adjuvant treatment after disease-directed surgery. External beam radiation was added to the treatment regimen for many patients diagnosed with Stage III and IV disease (30% in patients with papillary thyroid carcinoma and 33% in patients with follicular thyroid carcinoma).
    Conclusions: To the authors' knowledge no single effective diagnostic test for thyroid carcinoma currently is available and in the majority of cases a combination of ultrasound, thyroid scan, or fine-needle aspiration biopsy together with the clinical findings (e.g., thyroid mass) led to a diagnosis of carcinoma. The authors suspect that the high prevalence of concomitant pathologic findings such as goiter, even in the healthy population in Germany, reduces the accuracy of all diagnostic test methods and may account for the frequent use of imaging techniques. The majority of patients underwent a total or near-total thyroidectomy. Total thyroidectomy with radical lymph node dissection was used very frequently in those patients with papillary thyroid carcinoma (22%). German physicians tend to surgically treat early stage thyroid carcinoma somewhat more radically than recommended in the CPG. With respect to other treatment options employed as part of the first course of treatment, radioiodine appears to play the most important role. [See commentary o
    MeSH term(s) Adenocarcinoma, Follicular/pathology ; Adenocarcinoma, Follicular/therapy ; Adult ; Aged ; Carcinoma, Papillary/pathology ; Carcinoma, Papillary/therapy ; Diagnosis, Differential ; Female ; Germany ; Humans ; Iodine Radioisotopes ; Lymph Node Excision ; Male ; Middle Aged ; Practice Patterns, Physicians'/statistics & numerical data ; Prospective Studies ; Radiotherapy, Adjuvant ; Thyroid Neoplasms/pathology ; Thyroid Neoplasms/therapy ; Thyroidectomy
    Chemical Substances Iodine Radioisotopes
    Language English
    Publishing date 2000-07-01
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1429-1
    ISSN 1097-0142 ; 0008-543X ; 1934-662X
    ISSN (online) 1097-0142
    ISSN 0008-543X ; 1934-662X
    DOI 10.1002/1097-0142(20000701)89:1<192::aid-cncr26>3.0.co;2-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Two hundred eighty-six cases of parathyroid carcinoma treated in the U.S. between 1985-1995: a National Cancer Data Base Report. The American College of Surgeons Commission on Cancer and the American Cancer Society.

    Hundahl, S A / Fleming, I D / Fremgen, A M / Menck, H R

    Cancer

    1999  Volume 86, Issue 3, Page(s) 538–544

    Abstract: ... NCDB), a national electronic registry system currently capturing > 60% of incident cancers in the U. S ...

    Abstract Background: In combination with other Commission on Cancer programs, the National Cancer Data Base (NCDB), a national electronic registry system currently capturing > 60% of incident cancers in the U. S., offers a working example of voluntary, accurate, cost-effective "outcomes management" on a both a local and national scale. In addition, it is proving to be of particular value in capturing clinical information concerning rare cancers.
    Methods: For accession years 1985-1995, the NCDB captured prospectively collected demographic, stage, treatment, and outcome information for a national hospital-based sample of 286 parathyroid carcinoma cases (0.005% of the total NCDB cancer cases). This report describes clinical and demographic features as well as patterns of care and 5-year and 10-year relative survival rates.
    Results: The NCDB's 10-year accrual of parathyroid carcinoma cases exceeded the cumulative number reported in the English literature though 1991. Gender distribution was equal. The authors were unable to detect any disproportionate clustering by race, income level, or geographic region. Treatment overwhelmingly was surgical. The data from the current study suggest that neither tumor size nor lymph node status are significant prognostic factors. Overall relative survival at 5 years and 10 years was 85.5% and 49.1%, respectively.
    Conclusions: At 5 years of follow-up, and possibly beyond, neither tumor size nor lymph node status were found to be significant prognostic factors and basing a staging system on them would be useless. Although complete, en bloc resection of all tumor represents the best opportunity for cure, a substantial proportion of patients fail to receive such treatment. The authors speculate that the rarity of this condition and late intraoperative recognition occasionally prevent optimal treatment. [See editorial on pages 378-80, this issue.]
    MeSH term(s) Adolescent ; Adult ; Age Distribution ; Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Middle Aged ; Parathyroid Neoplasms/epidemiology ; Parathyroid Neoplasms/ethnology ; Parathyroid Neoplasms/mortality ; Parathyroid Neoplasms/pathology ; Parathyroid Neoplasms/therapy ; Parathyroidectomy/statistics & numerical data ; Sex Distribution ; United States/epidemiology
    Language English
    Publishing date 1999-08-01
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1429-1
    ISSN 1097-0142 ; 0008-543X ; 1934-662X
    ISSN (online) 1097-0142
    ISSN 0008-543X ; 1934-662X
    DOI 10.1002/(sici)1097-0142(19990801)86:3<538::aid-cncr25>3.0.co;2-k
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Nitro-fatty acids decrease type I interferons and monocyte chemoattractant protein 1 in ex vivo models of inflammatory arthritis.

    Hansen, A L / Rahbek, L S J / Sørensen, A S / Hundahl, M P / Lomholt, S / Holm, C K / Kragstrup, Tue W

    BMC immunology

    2021  Volume 22, Issue 1, Page(s) 77

    Abstract: Background: Inflammatory arthritis including rheumatoid arthritis (RA) and spondyloarthritis (SpA) is characterized by inflammation and destruction of the joints. Approximately one third of patients do not respond to first-line treatments. Nitro-fatty ... ...

    Abstract Background: Inflammatory arthritis including rheumatoid arthritis (RA) and spondyloarthritis (SpA) is characterized by inflammation and destruction of the joints. Approximately one third of patients do not respond to first-line treatments. Nitro-fatty acids are bioactive lipids with anti-inflammatory properties and tissue-protective functions. The nitro-fatty acid 10-NO
    Methods: Synovial fluid and blood samples were obtained from 14 patients with active RA or SpA. The in vitro models consisted of synovial fluid mononuclear cells (SFMCs) cultured for 48 h, SFMCs cultured for 21 days, and fibroblast-like synovial cells (FLSs) co-cultured with peripheral blood mononuclear cells (PBMCs) for 48 h. Cells were treated with or without 10-NO
    Results: In SFMCs cultured for 48 h, 10-NO
    Conclusion: 10-NO
    MeSH term(s) Adult ; Anti-Inflammatory Agents/metabolism ; Arthritis, Rheumatoid/metabolism ; Cells, Cultured ; Chemokine CCL2/metabolism ; Coculture Techniques ; Etanercept/pharmacology ; Female ; Fibroblasts/physiology ; Humans ; Interferon Type I/metabolism ; Leukocytes, Mononuclear/immunology ; Male ; Middle Aged ; Oleic Acids/metabolism ; Spondylitis, Ankylosing/metabolism ; Synovial Fluid/immunology
    Chemical Substances 10-nitro-oleic acid ; Anti-Inflammatory Agents ; Chemokine CCL2 ; Interferon Type I ; Oleic Acids ; Etanercept (OP401G7OJC)
    Language English
    Publishing date 2021-12-17
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2041500-X
    ISSN 1471-2172 ; 1471-2172
    ISSN (online) 1471-2172
    ISSN 1471-2172
    DOI 10.1186/s12865-021-00471-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Low maruyama index surgery for gastric cancer.

    Hundahl, S A

    Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society

    2006  Volume 95, Issue 4, Page(s) 243–248

    Abstract: Background: Japanese definitions and treatment guidelines have dominated extent-of-surgery concepts in gastric cancer for over 4 decades, despite the fact that such definitions/guidelines have changed considerably over time, and the fact they have ... ...

    Abstract Background: Japanese definitions and treatment guidelines have dominated extent-of-surgery concepts in gastric cancer for over 4 decades, despite the fact that such definitions/guidelines have changed considerably over time, and the fact they have largely failed to improve survival in prospective, randomized clinical trials.
    Aim: To briefly review lessons from previous surgical trials in gastric cancer, and, more specifically, to review data validating the concept of "low Maruyama Index surgery" as a data-driven guide to surgical treatment.
    Methods: Review of results from blinded multivariate analyses of two separate, prospective, randomized clinical trials: (a) the Macdonald Trial of adjuvant postoperative chemo-radiation, Intergroup 0116, conducted in North America; and (b) the Dutch D1-D2 Trial.
    Results: Blinded univariate and multivariate analysis of both trials establish "Maruyama Index of Unresected Disease" (MI) <5 as a strong independent predictor of better disease-free and overall survival in gastric cancer. Moreover, a strong "dose response" effect for MI versus survival is apparent.
    Conclusions: In contrast to surgery focused on achievement of a particular Japanese-defined D-level, "low Maruyama Index surgery" is associated with increased disease-free and overall survival. Further, the dose-response effect suggests MI can be used to quantify the adequacy of lymphadenectomy for a given patient. Low MI surgery can be prospectively planned by using the Maruyama Computer Program pre-operatively or intraoperatively.
    MeSH term(s) Gastrectomy ; Humans ; Lymph Node Excision ; Prognosis ; Randomized Controlled Trials as Topic ; Stomach Neoplasms/mortality ; Stomach Neoplasms/surgery
    Language English
    Publishing date 2006
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 2077691-3
    ISSN 1799-7267 ; 1457-4969
    ISSN (online) 1799-7267
    ISSN 1457-4969
    DOI 10.1177/145749690609500406
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the united states during 1996. U.S. and German Thyroid Cancer Study Group. An American College of Surgeons Commission on Cancer Patient Care Evaluation study.

    Hundahl, S A / Cady, B / Cunningham, M P / Mazzaferri, E / McKee, R F / Rosai, J / Shah, J P / Fremgen, A M / Stewart, A K / Hölzer, S

    Cancer

    2000  Volume 89, Issue 1, Page(s) 202–217

    Abstract: ... programs were invited to participate in this prospective cohort study of U.S. thyroid carcinoma cases ... a surveillance snapshot of current management of thyroid carcinoma in the U.S. Identified opportunities ...

    Abstract Background: The American College of Surgeons Commission on Cancer (CoC) has conducted national Patient Care Evaluation (PCE) studies since 1976.
    Methods: Over 1500 hospitals with CoC-approved cancer programs were invited to participate in this prospective cohort study of U.S. thyroid carcinoma cases treated in 1996. Follow-up will be conducted through the National Cancer Data Base.
    Results: Of the 5584 cases of thyroid carcinoma, 81% were papillary, 10% follicular, 3.6% Hürthle cell, 0.5% familial medullary, 2.7% sporadic medullary, and 1.7% undifferentiated/anaplastic. Demographics and suspected risk factors were analyzed. Fine-needle aspiration of the thyroid gland (53%) or a neck lymph node (7%), thyroid nuclear scan (39%), and ultrasound (38%) constituted the most frequently utilized diagnostic modalities. The vast majority of patients with differentiated thyroid carcinoma presented with American Joint Committee on Cancer Stage I and II disease and relatively small tumors. For all histologies, near-total or total thyroidectomy constituted the dominant surgical treatment. No lymph nodes were examined in a substantial proportion of cases. Residual tumor after the surgical event could be documented in 11% of cases, hypocalcemia in 10% of cases, and recurrent laryngeal nerve injury in 1.3% of cases. Complications were most frequently associated with total thyroidectomy combined with lymph node dissection. Thirty-day mortality was 0.3%; when undifferentiated/anaplastic cancer cases were eliminated, it decreased to 0.2%. Adjuvant treatment, probably underreported in this study, consisted of hormonal suppression (50% overall) and radioiodine (50% overall).
    Conclusions: In addition to offering information concerning risk factors and symptoms, the current PCE study compliments the survival information from previous NCDB reports and offers a surveillance snapshot of current management of thyroid carcinoma in the U.S. Identified opportunities for improvement of care include 1) more frequent use of fine-needle aspiration cytology in making a diagnosis; 2) more frequent use of laryngoscopy in evaluating patients preoperatively, especially those with voice change; and 3) improved lymph node resection and analysis to improve staging and, in some situations, outcomes.
    MeSH term(s) Adenocarcinoma, Follicular/pathology ; Adenocarcinoma, Follicular/surgery ; Adult ; Aged ; Biopsy, Needle ; Carcinoma, Papillary/pathology ; Carcinoma, Papillary/surgery ; Cohort Studies ; Female ; Follow-Up Studies ; Humans ; Lymph Node Excision ; Male ; Middle Aged ; Neoplasm Staging ; Prognosis ; Prospective Studies ; Risk Factors ; Thyroid Neoplasms/pathology ; Thyroid Neoplasms/surgery ; Treatment Outcome
    Language English
    Publishing date 2000-07-01
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1429-1
    ISSN 1097-0142 ; 0008-543X ; 1934-662X
    ISSN (online) 1097-0142
    ISSN 0008-543X ; 1934-662X
    DOI 10.1002/1097-0142(20000701)89:1<202::aid-cncr27>3.0.co;2-a
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Perspective: National Cancer Institute summary report about estimated exposures and thyroid doses received from iodine 131 in fallout after Nevada atmospheric nuclear bomb tests.

    Hundahl, S A

    CA: a cancer journal for clinicians

    1998  Volume 48, Issue 5, Page(s) 285–298

    Abstract: Environmental 131I contamination from atmospheric nuclear bomb tests conducted at the NTS from 1951 to 1958 exposed Americans nationwide to a cumulative average dose of 1 to 4 rad to the thyroid gland. By comparison, 10 years of exposure to natural ... ...

    Abstract Environmental 131I contamination from atmospheric nuclear bomb tests conducted at the NTS from 1951 to 1958 exposed Americans nationwide to a cumulative average dose of 1 to 4 rad to the thyroid gland. By comparison, 10 years of exposure to natural background sources of thyroid radiation results in a cumulative dose of 1 rad. Americans living in certain high-deposition areas received an average cumulative thyroid dose of as much as 16 rad. Individual dose rates vary considerably as a function of age at the time of exposure, site of residence, and dietary habits with respect to milk consumption. The individual cumulative thyroid dose for persons born between 1945 and 1958 may be significantly higher than the reported averages for their locale. The NCI report contains voluminous data tables permitting detailed calculations of individual dose. Additionally, color-coded dose maps allow one to approximate individual dose conveniently. Translation of cumulative thyroid dose attributable to 131I to predictions of increased rates of thyroid cancer appears problematic and is the subject of further study. In contrast to studies of patients receiving external thyroid irradiation, existing studies of patients treated with 131I for diagnostic and therapeutic medical purposes do not document increased rates of thyroid cancer. An Institute of Medicine task force is expected to issue a report on this subject in September 1998. This review also briefly summarizes the evaluation, diagnosis, and treatment of patients with papillary and follicular thyroid cancers. Data from 53,856 patients with thyroid cancer accessioned to the NCDB from 1985 to 1995 document extremely high survival rates for patients in the United States with papillary and follicular thyroid cancer.
    MeSH term(s) Adult ; Body Burden ; Female ; Humans ; Iodine Radioisotopes/adverse effects ; Iodine Radioisotopes/analysis ; Male ; Middle Aged ; National Institutes of Health (U.S.) ; Neoplasms, Radiation-Induced/etiology ; Neoplasms, Radiation-Induced/mortality ; Nevada ; Nuclear Warfare ; Radiation Monitoring ; Radioactive Fallout/adverse effects ; Radioactive Fallout/analysis ; Risk ; Survival Rate ; Thyroid Gland/radiation effects ; Thyroid Neoplasms/etiology ; Thyroid Neoplasms/mortality ; United States
    Chemical Substances Iodine Radioisotopes ; Radioactive Fallout
    Language English
    Publishing date 1998-09
    Publishing country United States
    Document type Journal Article
    ZDB-ID 603553-x
    ISSN 1542-4863 ; 0007-9235
    ISSN (online) 1542-4863
    ISSN 0007-9235
    DOI 10.3322/canjclin.48.5.285
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Gastric cancer nodal metastases: biologic significance and therapeutic considerations.

    Hundahl, S A

    Surgical oncology clinics of North America

    1996  Volume 5, Issue 1, Page(s) 129–144

    MeSH term(s) Gastrectomy ; Humans ; Lymph Node Excision ; Lymphatic Metastasis/pathology ; Stomach Neoplasms/mortality ; Stomach Neoplasms/pathology ; Stomach Neoplasms/surgery
    Language English
    Publishing date 1996-01
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 1196919-2
    ISSN 1558-5042 ; 1055-3207
    ISSN (online) 1558-5042
    ISSN 1055-3207
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Changing gastric cancer treatment in the United States and the pursuit of quality.

    Hundahl, S A / Wanebo, H J

    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

    2005  Volume 31, Issue 6, Page(s) 605–615

    Abstract: The low incidence of gastric cancer in the US presents various quality challenges. For most US practitioners, individual experience is inadequate. Accrual to clinical trials testing new treatments can be daunting. However, through the use of nationally ... ...

    Abstract The low incidence of gastric cancer in the US presents various quality challenges. For most US practitioners, individual experience is inadequate. Accrual to clinical trials testing new treatments can be daunting. However, through the use of nationally available clinical trials sponsored by many trial groups working in concert, and the use of national registries for treatment and outcome surveillance, a path to increased gastric cancer survival has been charted. Moreover, systems for continuous quality improvement at the institutional level are in place. Quality assurance is an increasing concern of both private and governmental groups. In this article, we summarize recent national US clinical trial findings concerning gastric cancer treatment, highlight national assessment systems for cancer outcomes, and describe what these systems tell us about the current status of gastric cancer care in the US, highlighting challenges and areas for potential improvement.
    MeSH term(s) Chemotherapy, Adjuvant ; Clinical Trials as Topic ; Humans ; Outcome and Process Assessment (Health Care) ; Quality Assurance, Health Care ; Radiotherapy, Adjuvant ; Stomach Neoplasms/surgery ; Stomach Neoplasms/therapy ; Treatment Outcome ; United States
    Language English
    Publishing date 2005-08
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 632519-1
    ISSN 0748-7983
    ISSN 0748-7983
    DOI 10.1016/j.ejso.2005.02.011
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top